| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.3 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.03 | 0.3 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.082 | 0.3 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |